IP Verse

Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription

Patent No. EP2800811 (titled "Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription") was filed by Charpentier on Mar 15, 2013. The application was issued on May 10, 2017.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (7)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
TRUSCOTTFeb 12, 2018GREAVES BREWSTER
ALLERGAN PHARMACEUTICALSFeb 11, 2018HOFFMANN EITLE
HGFFeb 9, 2018HGF
JONES DAYFeb 9, 2018JONES DAY
TL BRANDFeb 8, 2018SHARP
GRIEBLINGMay 12, 2017GRIEBLING
POHLMANMay 10, 2017POHLMAN

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2800811

CHARPENTIER
Application Number
EP13793997A
Filing Date
Mar 15, 2013
Status
Revoked
Nov 27, 2024
Publication Date
May 10, 2017
External Links
Slate, Register , Google Patents